Rhelixa-inc

Rhelixa is a leading company in epigenomic analysis, based in Tokyo, Japan. They provide services related to omics research, including genomic, epigenomic, transcriptomic, and metagenomic data analysis. Their expertise extends to professional scientific consulting, utilizing proprietary technology to enhance the efficiency and accuracy of research and development. Rhelixa also develops and operates cloud-based services to support omics research, such as their RIAS platform.

Rhelixa is committed to contributing to a prosperous society through their advancements in life sciences. Their mission is to accelerate the progress of life science research by providing cutting-edge technologies and services. They strive to ensure the quality and reliability of their offerings through various certifications, including JIS Q 27001:2014(ISO/IEC 27001:2013) for information security.

Rhelixa, Inc. is a leading company in epigenomic analysis committed to accelerating the advancement of life science research and contributing to the realization of a rich and fruitful society. They leverage cutting-edge genomic and epigenomic analysis techniques to develop and provide services like omics research, consulting, and cloud-based platforms, supporting both fundamental research and the development of products and solutions in the biological, medical, and pharmaceutical fields.

Rhelixa fosters a culture of innovation and collaboration, focused on accelerating the development of life science research for a richer and more fruitful society. They encourage their employees to take on challenges, grow continuously, and contribute to their field. The company emphasizes a team-oriented approach and provides a supportive environment for individual growth and development.